Clinical Pipeline and Indication

TEC-001 is applicable in all solid tumors with liver metastasis. We target the top 4 cancers (lung, colorectum, gastric and liver) with the highest global cancer-related deaths, as our priority to pursue. These 4 types of cancers all have a high incidence of liver metastasis, and a high unmet medical need which TEC-001 can contribute to.

The top 4 cancers comprise 44% of worldwide cancer-related deaths.
Contact Us

New Jersey:

26 Park Street, Suite 100,
Montclair, NJ 07042

Taiwan:

10F., No.124, Sec. 2, Nanjing East Road,
Taipei, Taiwan (R.O.C.) 10489

Email:

info@teclison.com

© 2021 Teclison Limited. All rights reserved.